Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea
- S-Med
- Jun 21, 2023
- 1 min read
Unilateral transvenous PNS with Remedē System in patients with CSA is associated with a high response to therapy through 36 months follow-up as well as echocardiography parameters through 24 months. The benefits appear to be sustained with no safety concerns.
Comentários